Oxycodone Completed Phase 3 Trials for Malignancies / Pain NOS Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01675622Immediate-Release Oxycodone Capsules Study in Cancer Pain
NCT01885182Targin Cancer Pain
NCT00654069Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy
NCT01192295Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
NCT01369615Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
NCT01167127Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167699Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01559701Long-term Safety of PF-00345439 (Oxycodone)
NCT00261495A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.